0001099219-26-000019
SEC filingMetLife disclosed preliminary Q1 2026 variable investment income of $475–$525 million (pre-tax), representing an estimated 29.7%–32.8% of its full-year 2026 guidance of $1.6 billion, with explicit caveats that the figures are unaudited and subject to material revision upon financial close.
This Item 7.01 disclosure provides preliminary, unaudited estimates for MetLife’s variable investment income — a non-operating, market-sensitive line item comprising returns from private equity, real estate, and other alternative investments, plus prepayment fees. The $475–$525 million range for Q1 2026 represents roughly one-third of the company’s full-year 2026 guidance of $1.6 billion, suggesting either uneven quarterly distribution across the year or conservative annual guidance. Management explicitly disclaims reliability: the figures are based on incomplete financial closing procedures and carry no GAAP assurance. Because variable investment income is inherently lumpy and not tied to core insurance underwriting or asset-liability management, its variability does not reflect operational trends in life insurance, annuities, or group benefits — the primary drivers of MetLife’s earnings stability. Investors should treat this as a narrow, forward-looking signal about alternative investment performance rather than a proxy for overall profitability. The absence of comparative period data (e.g., Q1 2025) or margin context further constrains analytical utility. Final validation awaits the May 6, 2026 earnings release and financial supplement, which will include GAAP-compliant results, segment-level detail, and management commentary on drivers and outlook.